Nuzenio

Oncology Drugs

Oncology Drugs news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 17 publisher sources 100/100 entity strength

Latest news

First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models - Pharmacy TimesPharmacy Times · Mon, 10 Aug 2026 19:16:31 GMTITM cancer drug spurned by FDA over manufacturing qualms - Fierce PharmaFierce Pharma · Mon, 10 Aug 2026 15:25:54 GMTNBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials - OncodailyOncodaily · Mon, 10 Aug 2026 14:23:40 GMTThe Cancer Economy: How a Chemical Age Turns Disease into Revenue - The People's PharmacyThe People's Pharmacy · Mon, 10 Aug 2026 13:16:33 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - statnews.comstatnews.com · Mon, 10 Aug 2026 11:33:33 GMTStudy suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt and resist treatment - Medical XpressMedical Xpress · Mon, 10 Aug 2026 11:20:03 GMTThe promise of radiopharmaceuticals smacks into safety concerns - statnews.comstatnews.com · Mon, 10 Aug 2026 08:33:33 GMTGeneric Oncology Sterile Injectable Market Report Examines Leading Companies And Growth Opportunities - EIN NewsEIN News · Mon, 10 Aug 2026 05:44:00 GMT

Timeline

Mon, 10 Aug 2026 19:16:31 GMTFirst-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models - Pharmacy Times
Mon, 10 Aug 2026 15:25:54 GMTITM cancer drug spurned by FDA over manufacturing qualms - Fierce Pharma
Mon, 10 Aug 2026 14:23:40 GMTNBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials - Oncodaily
Mon, 10 Aug 2026 13:16:33 GMTThe Cancer Economy: How a Chemical Age Turns Disease into Revenue - The People's Pharmacy
Mon, 10 Aug 2026 11:33:33 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - statnews.com
Mon, 10 Aug 2026 11:20:03 GMTStudy suggests experimental drug dismantles 2 key proteins that help tumors survive, adapt and resist treatment - Medical Xpress

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncology Drugs.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.